RABIH C FAHED
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- NORFOLK, NE
- NPI
- 1043488844
- Received
- $294,122 in 538 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 79 | $16,489 |
| 2024 | General payment | 33 | $23,449 |
| 2023 | General payment | 63 | $53,115 |
| 2022 | General payment | 65 | $48,943 |
| 2021 | General payment | 36 | $26,586 |
| 2020 | General payment | 60 | $38,035 |
| 2019 | General payment | 202 | $87,502 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 87 | $201,185 |
| Consulting Fee | 63 | $57,749 |
| Travel and Lodging | 78 | $19,566 |
| Food and Beverage | 282 | $8,584 |
| Honoraria | 8 | $6,525 |
| Education | 20 | $511 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-12-23 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-12-17 | PharmaEssentia USA Corporation | $117 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-12-17 | SERVIER PHARMACEUTICALS LLC | $17 | Food and Beverage | In-kind items and services | Voranigo Drug, Oncology | 2025 | |
| 2025-12-08 | Kite Pharma, Inc. | $17 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-12-05 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2025 | |
| 2025-12-05 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2025 | |
| 2025-11-19 | Astellas Pharma US Inc | $116 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-11-18 | Janssen Biotech, Inc. | $14 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2025 | |
| 2025-11-13 | JAZZ PHARMACEUTICALS INC. | $16 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-11-12 | Ipsen Biopharmaceuticals, Inc | $27 | Food and Beverage | In-kind items and services | Onivyde Drug, Oncology | 2025 | |
| 2025-11-06 | Bayer Healthcare Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-10-30 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-10-28 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-10-28 | PFIZER INC. | $2 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-10-24 | Genmab U.S., Inc. | $24 | Food and Beverage | In-kind items and services | Epkinly Drug, Oncology | 2025 | |
| 2025-10-22 | Karyopharm Therapeutics Inc. | $19 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-10-08 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | LUPRON DEPOT Drug, ENDOCRINOLOGY | 2025 | |
| 2025-10-07 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-09-30 | SOBI, INC | $18 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-09-29 | SEAGEN INC. | $79 | Education | In-kind items and services | 2025 | ||
| 2025-09-29 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-09-29 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-09-26 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-09-23 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2025 | |
| 2025-09-17 | E.R. Squibb & Sons, L.L.C. | $355 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-10 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-09-09 | SERVIER PHARMACEUTICALS LLC | $27 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2025 | |
| 2025-09-08 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2025 | |
| 2025-09-04 | Astellas Pharma US Inc | $21 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-09-04 | Astellas Pharma US Inc | $9 | Education | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-09-04 | Astellas Pharma US Inc | $9 | Education | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-08-26 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-08-25 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-08-25 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-08-25 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-08-19 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-08-14 | Rigel Pharmaceuticals, Inc. | $15 | Food and Beverage | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-08-12 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-08-12 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-08-06 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2025 | |
| 2025-07-30 | Syndax Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-23 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-07-21 | E.R. Squibb & Sons, L.L.C. | $1,420 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-21 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-07-16 | Geron Corporation | $780 | Consulting Fee | Cash or cash equivalent | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-07-16 | Janssen Biotech, Inc. | $14 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2025 | |
| 2025-07-15 | E.R. Squibb & Sons, L.L.C. | $355 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-09 | Acrotech Biopharma Inc. | $15 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2025 | |
| 2025-06-16 | PFIZER INC. | $7 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-06-16 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-06-16 | PFIZER INC. | $0 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-06-09 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2025 | |
| 2025-05-30 | E.R. Squibb & Sons, L.L.C. | $1,420 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-21 | Genentech USA, Inc. | $14 | Food and Beverage | In-kind items and services | Tecentriq Biological, BioOncology | 2025 | |
| 2025-05-15 | E.R. Squibb & Sons, L.L.C. | $1,420 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-12 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-05-12 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-05-07 | AstraZeneca Pharmaceuticals LP | $5,360 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-05-06 | AstraZeneca Pharmaceuticals LP | $2,010 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-05-05 | AstraZeneca Pharmaceuticals LP | $353 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-05-01 | AstraZeneca Pharmaceuticals LP | $285 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-05-01 | AstraZeneca Pharmaceuticals LP | $120 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-29 | ABBVIE INC. | $104 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-04-22 | Iovance Biotherapeutics, Inc. | $11 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-04-18 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-04-10 | E.R. Squibb & Sons, L.L.C. | $355 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-09 | Blueprint Medicines Corporation | $23 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2025 | |
| 2025-04-01 | E.R. Squibb & Sons, L.L.C. | $355 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-28 | Aveo Pharmaceuticals, Inc. | $20 | Education | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-03-12 | AstraZeneca Pharmaceuticals LP | $6 | Education | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-03-10 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2025 | |
| 2025-03-06 | Astellas Pharma US Inc | $18 | Education | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-03-06 | Astellas Pharma US Inc | $18 | Education | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-03-03 | Genentech USA, Inc. | $15 | Food and Beverage | In-kind items and services | Itovebi Biological, BioOncology | 2025 | |
| 2025-02-17 | PharmaEssentia USA Corporation | $24 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-02-11 | Aveo Pharmaceuticals, Inc. | $20 | Education | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-02-10 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-01-24 | Genentech USA, Inc. | $26 | Food and Beverage | In-kind items and services | Columvi Biological, BioOncology | 2025 | |
| 2024-12-12 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-12-09 | E.R. Squibb & Sons, L.L.C. | $1,437 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-01 | AstraZeneca Pharmaceuticals LP | $1,340 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-10-23 | E.R. Squibb & Sons, L.L.C. | $3,073 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-10-23 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-10-23 | Immunocore Limited | $17 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2024 | |
| 2024-10-15 | E.R. Squibb & Sons, L.L.C. | $294 | Travel and Lodging | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-10-10 | E.R. Squibb & Sons, L.L.C. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-10-07 | SOBI, INC | $200 | Consulting Fee | Cash or cash equivalent | VONJO Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-10-03 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2024 | |
| 2024-10-01 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-10-01 | E.R. Squibb & Sons, L.L.C. | $84 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-09-24 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2024 | |
| 2024-08-29 | AstraZeneca Pharmaceuticals LP | $4,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-08-21 | AstraZeneca Pharmaceuticals LP | $190 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2024 | |
| 2024-08-21 | AstraZeneca Pharmaceuticals LP | $125 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2024 | |
| 2024-08-06 | Janssen Biotech, Inc. | $6 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-07-31 | E.R. Squibb & Sons, L.L.C. | $4,829 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-07-31 | E.R. Squibb & Sons, L.L.C. | $187 | Travel and Lodging | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-07-31 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | LUPRON DEPOT Drug, ENDOCRINOLOGY | 2024 | |
| 2024-07-17 | E.R. Squibb & Sons, L.L.C. | $126 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-07-15 | Janssen Biotech, Inc. | $138 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2024 | |
| 2024-06-25 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-06-21 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-06-18 | E.R. Squibb & Sons, L.L.C. | $600 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-06-07 | Aveo Pharmaceuticals, Inc. | $15 | Education | In-kind items and services | FOTIVDA Drug, Oncology | 2024 | |
| 2024-06-06 | Exelixis Inc. | $116 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-06-06 | KYOWA KIRIN, INC. | $16 | Food and Beverage | In-kind items and services | Poteligeo Drug, Monoclonal Antibody | 2024 | |
| 2024-05-24 | BeiGene USA, Inc. | $1,925 | Consulting Fee | Cash or cash equivalent | BRUKINSA Drug, Oncology | 2024 | |
| 2024-05-24 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-01-30 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2024 | |
| 2024-01-18 | Tempus AI, Inc | $18 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-10 | TAIHO ONCOLOGY, INC. | $1,412 | Consulting Fee | Cash or cash equivalent | LONSURF Drug, Oncology | 2024 | |
| 2023-12-29 | E.R. Squibb & Sons, L.L.C. | $600 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-12-13 | Eisai Inc. | $116 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2023 | |
| 2023-10-17 | Bayer Healthcare Pharmaceuticals Inc. | $196 | Consulting Fee | Cash or cash equivalent | Vitrakvi Drug, Oncology | 2023 | |
| 2023-10-10 | Janssen Biotech, Inc. | $116 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-09-22 | E.R. Squibb & Sons, L.L.C. | $600 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-09-21 | AstraZeneca Pharmaceuticals LP | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-09-19 | AstraZeneca Pharmaceuticals LP | $4,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-08-31 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2023 | |
| 2023-08-25 | Eisai Inc. | $18 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2023 | |
| 2023-08-24 | GENZYME CORPORATION | $1,238 | Consulting Fee | Cash or cash equivalent | SARCLISA Biological, Oncology | 2023 | |
| 2023-08-22 | AstraZeneca Pharmaceuticals LP | $290 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-08-22 | AstraZeneca Pharmaceuticals LP | $135 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-08-16 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-08-10 | SEAGEN INC. | $8,612 | Consulting Fee | Cash or cash equivalent | ADCETRIS Biological, Oncology | 2023 | |
| 2023-08-09 | Gilead Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-07-27 | ABBVIE INC. | $900 | Consulting Fee | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2023 | |
| 2023-07-27 | AstraZeneca Pharmaceuticals LP | $525 | Consulting Fee | Cash or cash equivalent | CALQUENCE Drug, Oncology | 2023 | |
| 2023-07-16 | SEAGEN INC. | $50 | Travel and Lodging | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-16 | SEAGEN INC. | $28 | Travel and Lodging | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-15 | SEAGEN INC. | $558 | Travel and Lodging | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-15 | SEAGEN INC. | $292 | Travel and Lodging | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-15 | SEAGEN INC. | $185 | Travel and Lodging | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-15 | SEAGEN INC. | $62 | Food and Beverage | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-15 | SEAGEN INC. | $57 | Food and Beverage | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-15 | SEAGEN INC. | $42 | Food and Beverage | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-14 | SEAGEN INC. | $150 | Travel and Lodging | In-kind items and services | ADCETRIS Biological, Oncology | 2023 | |
| 2023-07-05 | Regeneron Healthcare Solutions, Inc. | $732 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2023 | |
| 2023-06-21 | E.R. Squibb & Sons, L.L.C. | $300 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-06-15 | Exelixis Inc. | $1,960 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CABOMETYX Drug, Oncology | 2023 | |
| 2023-06-14 | Janssen Biotech, Inc. | $1,350 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-06-09 | AstraZeneca Pharmaceuticals LP | $4,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-06-08 | Regeneron Healthcare Solutions, Inc. | $586 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2023 | |
| 2023-06-07 | AstraZeneca Pharmaceuticals LP | $183 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-06-07 | AstraZeneca Pharmaceuticals LP | $129 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-05-13 | Exelixis Inc. | $224 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-13 | Exelixis Inc. | $145 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-13 | Exelixis Inc. | $77 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-13 | Exelixis Inc. | $44 | Travel and Lodging | Cash or cash equivalent | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-12 | Exelixis Inc. | $489 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-12 | Exelixis Inc. | $130 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-12 | Exelixis Inc. | $79 | Travel and Lodging | In-kind items and services | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-12 | Exelixis Inc. | $31 | Food and Beverage | Cash or cash equivalent | CABOMETYX Drug, Oncology | 2023 | |
| 2023-05-11 | Incyte Corporation | $106 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2023 | |
| 2023-05-01 | AstraZeneca Pharmaceuticals LP | $4,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-04-28 | E.R. Squibb & Sons, L.L.C. | $5,268 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-04-28 | AstraZeneca Pharmaceuticals LP | $1,650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-04-28 | AstraZeneca Pharmaceuticals LP | $1,650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-04-20 | AstraZeneca Pharmaceuticals LP | $432 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-04-20 | AstraZeneca Pharmaceuticals LP | $410 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-04-20 | AstraZeneca Pharmaceuticals LP | $28 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-04-18 | E.R. Squibb & Sons, L.L.C. | $137 | Travel and Lodging | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-04-11 | E.R. Squibb & Sons, L.L.C. | $118 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-03-15 | AstraZeneca Pharmaceuticals LP | $4,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2023 | |
| 2023-03-14 | Regeneron Healthcare Solutions, Inc. | $976 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2023 | |
| 2023-03-02 | AstraZeneca Pharmaceuticals LP | $146 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-03-02 | AstraZeneca Pharmaceuticals LP | $61 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2023 | |
| 2023-03-02 | Janssen Biotech, Inc. | $6 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2023 | |
| 2023-02-22 | E.R. Squibb & Sons, L.L.C. | $3 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-02-08 | E.R. Squibb & Sons, L.L.C. | $300 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-02-07 | E.R. Squibb & Sons, L.L.C. | $5 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2023 | |
| 2023-01-31 | Regeneron Healthcare Solutions, Inc. | $976 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2023 | |
| 2023-01-23 | E.R. Squibb & Sons, L.L.C. | $4 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2023-01-17 | E.R. Squibb & Sons, L.L.C. | $1,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OPDIVO Biological, Oncology | 2023 | |
| 2022-12-30 | E.R. Squibb & Sons, L.L.C. | $300 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-12-20 | Regeneron Healthcare Solutions, Inc. | $1,085 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2022 | |
| 2022-12-20 | Regeneron Healthcare Solutions, Inc. | $1,085 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2022 | |
| 2022-12-14 | E.R. Squibb & Sons, L.L.C. | $300 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-12-13 | Regeneron Healthcare Solutions, Inc. | $1,085 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2022 | |
| 2022-12-06 | Incyte Corporation | $700 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-12-05 | AstraZeneca Pharmaceuticals LP | $4,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2022 | |
| 2022-11-23 | BeiGene USA, Inc. | $525 | Consulting Fee | Cash or cash equivalent | BRUKINSA Drug, Oncology | 2022 | |
| 2022-11-22 | Regeneron Healthcare Solutions, Inc. | $1,085 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2022 | |
| 2022-11-21 | E.R. Squibb & Sons, L.L.C. | $3,925 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OPDIVO Biological, Oncology | 2022 | |
| 2022-11-17 | AstraZeneca Pharmaceuticals LP | $124 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2022 | |
| 2022-11-17 | AstraZeneca Pharmaceuticals LP | $107 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2022 | |
| 2022-11-09 | E.R. Squibb & Sons, L.L.C. | $94 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2022 | |
| 2022-11-08 | Incyte Corporation | $5 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2022 | |
| 2022-11-08 | Incyte Corporation | $0 | Food and Beverage | Cash or cash equivalent | PEMAZYRE Drug, Hepatology (Liver, Pancreatic, Gall Bladder) | 2022 | |
| 2022-11-04 | Regeneron Healthcare Solutions, Inc. | $651 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2022 | |
| 2022-11-02 | AstraZeneca Pharmaceuticals LP | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2022 | |
| 2022-10-19 | Blueprint Medicines Corporation | $47 | Food and Beverage | In-kind items and services | AYVAKIT Drug, Oncology / Rare Diseases | 2022 | |
| 2022-10-17 | AstraZeneca Pharmaceuticals LP | $8 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2022 | |
| 2022-10-06 | Regeneron Healthcare Solutions, Inc. | $1,085 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2022 | |
| 2022-09-19 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | IMFINZI Biological, Oncology | 2022 | |
| 2022-09-12 | Celgene Corporation | $600 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-07-28 | Pharmacyclics LLC, an AbbVie Company | $115 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2022 | |
| 2022-07-27 | GENZYME CORPORATION | $1,953 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LIBTAYO Biological, Oncology | 2022 | |
| 2022-06-28 | E.R. Squibb & Sons, L.L.C. | $135 | Travel and Lodging | Cash or cash equivalent | OPDIVO Biological, Oncology | 2022 |
The latest 200 records of 538.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Norfolk, NE, county Madison County, NE, state Nebraska; placed by its city name.
| Measure | Place (city or town) Norfolk, NE | County Madison County, NE | State Nebraska |
|---|---|---|---|
| Population B01003 | 26,054 | 35,532 | 1,978,707 |
| Population, 2020 census P1 | 24,955 | 35,585 | 1,961,504 |
| Median age B01002 | 37.3 | 37.4 | 37.2 |
| Under 18 B01001 | 24.2% | 25.3% | 24.5% |
| 65 and over B01001 | 17.4% | 17.4% | 16.7% |
| Households B11001 | 10,990 | 14,462 | 797,847 |
| Foreign born B05002 | 7.1% | 8.0% | 8.0% |
| Median household income B19013 | $58,884 | $63,128 | $76,475 |
| Median family income B19113 | $84,000 | $85,348 | $99,751 |
| Per capita income B19301 | $36,131 | $36,105 | $41,751 |
| Poverty rate B17001 | 14.3% | 13.1% | 10.6% |
| Unemployment rate B23025 | 3.2% | 3.0% | 3.0% |
| Civilian labor force B23025 | 13,784 | 18,478 | 1,056,746 |
| Mean commute (minutes) B08013 | 13.0 | 14.3 | 19.2 |
| Bachelor's degree or higher B15003 | 24.0% | 23.7% | 34.6% |
| Housing units B25001 | 11,786 | 15,510 | 863,444 |
| Owner-occupied B25003 | 60.9% | 65.4% | 66.5% |
| Renters B25003 | 39.1% | 34.6% | 33.5% |
| Median home value B25077 | $211,700 | $208,500 | $238,600 |
| Median gross rent B25064 | $875 | $881 | $1,072 |
| White, not Hispanic B03002 | 77.9% | 77.2% | 75.3% |
| Black B03002 | 1.0% | 0.8% | 4.6% |
| Hispanic or Latino B03002 | 15.5% | 16.3% | 12.7% |
| Asian B03002 | 1.0% | 1.3% | 2.6% |
| American Indian and Alaska Native B03002 | 1.1% | 0.9% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Norfolk, NE.
Comments